report by BlackRock
Results for ""
Market Outlooks
Weekly Market Compass: As COVID cases rise, will Powell address Fed tapering?
This piece is approved to use with clients.
Over the last several weeks, the idea that COVID-19 would soon be a problem of the past was dashed with recent data. Countries such as Israel — which I’ve described as the “gold standard” of vaccine rollouts — and the United States are experiencing a surge in COVID-19 infections.
Market Outlooks
Weekly Macro Update: Globalization is Still Strong, but Changing
This piece is approved to use with clients.
Global integration has clearly not stopped, but it is changing. Even with the pandemic’s disruption of global supply chains and rising U.S.-China tensions, investors should continue to count on a world that seems to be further integrating, rather than falling apart.
Market Outlooks
Weekly Market Compass: The Fed’s foreshadowing may help avoid another ‘taper tantrum’
This piece is approved to use with clients.
It’s “back to school” season in many parts of the world, which always brings back warm memories for me.
Market Outlooks
Weekly Market Compass: A closer look at the Chinese tech sell-off
This piece is approved to use with clients.
I often use this blog as an opportunity to answer pressing questions from clients. And recently, it seems almost all the questions we are getting are about China – what is going on with Chinese stocks and whether investors should abandon them.
Market Outlooks
Weekly Market Compass: What’s driving low Treasury yields?
This piece is approved to use with clients.
Last week, we saw yields on US Treasuries reach fresh multi-month lows. The 10-year yield fell to 1.25% during the week, although it was able to finish the week modestly higher.
Market Outlooks
Weekly Macro Update: No Stopping China’s Restocking
This piece is approved to use with clients.
FIFO gives China the global distribution edge across export sectors, even those that fell.
Market Outlooks
Weekly Market Compass: Markets watch closely as variants reshape COVID landscape
This piece is approved to use with clients.
Variants emerge as a global concern
The Delta variant (B.1.617) is spreading at a rapid rate, which has caused the World Health
Market Outlooks
Weekly Macro Update: What Will Kill This Market?
This piece is approved to use with clients.
Something will at some point, but the most plausible downside scenarios still look like a stretch for this year and next.
Market Outlooks
Weekly Macro Update: The Emerging Markets Recovery & The Race Ahead
This piece is approved to use with clients.
With the Fed’s “tapering” clock now officially ticking, many Emerging Markets face an even more urgent challenge to tackle the pandemic.
Market Outlooks
Tech stocks’ short-term struggles may lead to long-term buying opportunities
This piece is approved to use with clients.
Technology stocks have been under pressure this year — thus far, the tech sector has been the second-worst-performing sector in the S&P 500 Index in 2021.1 However, while I don’t expect tech stocks to lead the market in performance very soon, I think there are some compelling reasons for investors with a long time horizon to treat any significant tech sell-offs as buying opportunities.
Market Outlooks
Weekly Market Compass: Four truths about inflation and the Fed
This piece is approved to use with clients.
Last week, investors shuddered as data showed a big rise in prices in the US and a greater-than-expected rise in prices in the eurozone. Stocks sold off, US Treasury yields climbed higher, and market pundits obsessed over inflation. I feel it’s important at this juncture to remind investors of a few truths surrounding inflation and the Federal Reserve.
Market Outlooks
Weekly Macro Update: Approaching Apogee
This piece is approved to use with clients.
Even as the U.S. economy rockets higher, last week's jobs miss will start to raise questions about what is a sustainable trajectory.